Identification of the metabolic protein ATP5MF as a potential therapeutic target of TNBC
Abstract Background Triple-negative breast cancer (TNBC), a distinct subtype of breast cancer, is characterized by its high invasiveness, high metastatic potential, proneness to relapse, and poor prognosis. Effective treatment regimens for non-BRCA1/2 mutation TNBC are still lacking. As a result, th...
Saved in:
| Main Authors: | Kaiyan Chen, Yingchun Wu, Linfeng Xu, Changyong Wang, Jinqiu Xue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-024-05692-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SLC7A5: A Potential Molecular Target for the Diagnosis and Treatment of TNBC
by: Xiong Jing, et al.
Published: (2025-01-01) -
The role of ATP6V0D2 in breast cancer: associations with prognosis, immune characteristics, and TNBC progression
by: Jingyu Zhang, et al.
Published: (2024-11-01) -
Pan-cancer analysis and validation of NT5DC2: emphasizing its prognostic significance and immunological role in TNBC
by: Qing Luo, et al.
Published: (2025-07-01) -
Enhancing Osteogenesis through Bio‐Inspired Recombinant Coral Protein Galaxin by Targeting Mitochondrial Metabolism and ATP Production
by: Fei Yu, et al.
Published: (2025-05-01) -
CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis
by: Qiong Yuan, et al.
Published: (2025-08-01)